Skip to main content
Advertisement
Menu
Search
Search
Publisher main menu




Journals
Submissions
Publishing services
About
My Account
Follow BioMed Central


Twitter
Facebook
Arthritis Research & Therapy
Arthritis Research & Therapy main menu



Home
About
Articles
Articles


Recent
Most accessed
Recent articles
Recent articles RSS
1. Research article
Evaluation of the impact of fibromyalgia in disease activity and treatment
effect in spondyloarthritis
Natalia Bello, Adrien Etcheto, Caroline Béal, Maxime Dougados and Anna Moltó
Published on: 9 February 2016
2. Research article
Rheumatoid factor isotypes in relation to antibodies against citrullinated
peptides and carbamylated proteins before the onset of rheumatoid
arthritis
Mikael Brink, Monika Hansson, Linda Mathsson-Alm, Priyantha Wijayatunga, Marije K.
Verheul, Leendert A. Trouw, Rikard Holmdahl, Johan Rönnelid, Lars Klareskog and
Solbritt Rantapää-Dahlqvist
Published on: 9 February 2016
3. Letter
Response to: ‘A dose–response relationship between severity of disc
degeneration and intervertebral disc height in the lumbosacral spine’
Kaj S. Emanuel, Idsart Kingma, Marco N. Helder and Theodoor H. Smit
Published on: 8 February 2016
4. Editorial
The crowded crossroad to angiogenesis in systemic sclerosis: where is the
key to the problem?
Mirko Manetti, Serena Guiducci and Marco Matucci-Cerinic
Published on: 5 February 2016
5. Research article
Tapering and discontinuation of TNF-α blockers without disease relapse
using ultrasonography as a tool to identify patients with rheumatoid
arthritis in clinical and histological remission
Stefano Alivernini, Giusy Peluso, Anna Laura Fedele, Barbara Tolusso, Elisa Gremese
and Gianfranco Ferraccioli
Published on: 3 February 2016
View all articles
Most accessed articles
Most accessed articles RSS
1. Review
Use of NSAIDs in treating patients with arthritis
Leslie J Crofford
Published on: 24 July 2013
2. Research article
Collagen-induced arthritis in common marmosets: a new nonhuman
primate model for chronic arthritis
Michel PM Vierboom, Elia Breedveld, Ivanela Kondova and Bert A 't Hart
Published on: 26 October 2010
3. Research article
Remission in psoriatic arthritis: is it possible and how can it be predicted?
Tajvur P Saber, CT Ng, Guillaume Renard, Bernadette M Lynch, Eliza Pontifex, Ceara
AE Walsh, Alexia Grier, Marian Molloy, Barry Bresnihan, Oliver FitzGerald, Ursula
Fearon and Douglas J Veale
Published on: 18 May 2010
4. Review
Microbes, the gut and ankylosing spondylitis
Mary-Ellen Costello, Dirk Elewaut, Tony J Kenna and Matthew A Brown
Published on: 6 June 2013
5. Research article
Cartilage oligomeric matrix protein specific antibodies are pathogenic
Hui Geng, Kutty Selva Nandakumar, Anna Pramhed, Anders Aspberg, Ragnar Mattsson
and Rikard Holmdahl
Published on: 20 August 2012
View all articles
Article collections
Measuring meaningful change in lupus clinical trials
Biology and clinical applications of stem cells for autoimmune and musculoskeletal disorders
At the interface between immunology and neurology in rheumatic diseases
View all collections
Editors-in-Chief
Professor Christopher Buckley, University of Birmingham, UK
Professor Harris Perlman, Northwestern University, USA
Aims and scope
Arthritis Research & Therapy is an international, peer-reviewed online journal, publishing
original research, reviews, commentaries and reports. The major focus of the journal is on
cellular and molecular mechanisms of arthritis, musculoskeletal conditions and systemic
autoimmune rheumatic diseases and translation of this knowledge into advances in clinical care.
Original basic, translational laboratory and clinical research is considered for publication along
with results of early and late phase therapeutic trials.
Review series: New technologies
Written by renowned experts in the field, this collection of open access Review articles explores
the use of RNA sequencing, cytometry, metabolomics and next-generation DNA sequencing in
rheumatic disease.
Reflections of a rheumatologist
Rheumatoid vasculitis: going, going, but not yet gone
Read more from David Pisetsky
Featured review: Progress in defining clinically meaningful
changes for clinical trials in nonrenal manifestations of SLE
disease activity
“Since 2002, one new agent has been approved by the US Food and Drug Administration
for systemic lupus erythematosus (SLE). Experiences from the field conducting trials of all the
agents tested during this period have provided valuable practical insights. These insights
harnessed with basic methodological work on the minimal clinically important difference
(MCID) should improve the efficiency and the clinical relevance of future trials.”
This review, by Choi et al., provides an update on methods to determine a clinically meaningful
difference when conducting trials of new agents for SLE.
Submit a manuscript
Impact Factor: 3.75



Submission Guidelines
Editorial Board
Sign up to article alerts
Follow

Follow us on Twitter
ISSN:
1478-6362
Advertisement






Contact us
Jobs
Manage manuscripts
Sign up for article alerts
Manage article alerts
Leave feedback


Press center
Read more on our blogs






Policies
Licensing
Terms and conditions
Privacy statement
Accessibility
Cookies
Follow BioMed Central







Twitter
Facebook
Google Plus
YouTube
LinkedIn
Reddit
Weibo
© 2016 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.
By continuing to use this website, you agree to our Terms and Conditions, Privacy statement and
Cookies policy.